CoChat

G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling

Riaz, Anjum, Huang, Ying, Johansson, Staffan · 2016 · International Journal of Molecular Sciences
Cited by 66

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

A hallmark of G-protein-coupled receptors (GPCRs) is their ability to recognize and respond to chemically diverse ligands. Lysophospholipids constitute a relatively recent addition to these ligands and carry out their biological functions by activating G-proteins coupled to a large family of cell-surface receptors. This review aims to highlight salient features of cell signaling by one class of these receptors, known as lysophosphatidic acid (LPA) receptors, in the context of phosphatidylinositol 3-kinase (PI3K)–AKT pathway activation. LPA moieties efficiently activate AKT phosphorylation and activation in a multitude of cell types. The interplay between LPA, its receptors, the associated Gαi/o subunits, PI3K and AKT contributes to the regulation of cell survival, migration, proliferation and confers chemotherapy-resistance in certain cancers. However, detailed information on the regulation of PI3K–AKT signals induced by LPA receptors is missing from the literature. Here, some urgent issues for investigation are highlighted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17020215

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 102

  1. Choi, 2010, Lpa receptors: Subtypes and biological actions, Annu. Rev. Pharmacol. Toxicol., 50, 157, 10.1146/annurev.pharmtox.010909.105753 · DOI · Paper page
  2. Moolenaar, 1999, Bioactive lysophospholipids and their G protein-coupled receptors, Exp. Cell Res., 253, 230, 10.1006/excr.1999.4702 · DOI · Paper page
  3. Aoki, 2002, Serum lysophosphatidic acid is produced through diverse phospholipase pathways, J. Biol. Chem., 277, 48737, 10.1074/jbc.M206812200 · DOI · Paper page
  4. Choi, 2013, Lysophospholipids and their receptors in the central nervous system, Biochim. Biophys. Acta, 1831, 20, 10.1016/j.bbalip.2012.07.015 · DOI · Paper page
  5. Yung, 2014, Lpa receptor signaling: Pharmacology, physiology, and pathophysiology, J. Lipid Res., 55, 1192, 10.1194/jlr.R046458 · DOI · Paper page
  6. Hama, 2002, Lysophosphatidic acid (Lpa) receptors are activated differentially by biological fluids: Possible role of lpa-binding proteins in activation of lpa receptors, FEBS Lett., 523, 187, 10.1016/S0014-5793(02)02976-9 · DOI
  7. Bandoh, 2000, Lysophosphatidic acid (Lpa) receptors of the edg family are differentially activated by lpa species: Structure–activity relationship of cloned Lpa receptors, FEBS Lett., 478, 159, 10.1016/S0014-5793(00)01827-5 · DOI · Paper page
  8. Aoki, 2008, Two pathways for lysophosphatidic acid production, Biochim. Biophys. Acta (BBA), 1781, 513, 10.1016/j.bbalip.2008.06.005 · DOI · Paper page
  9. Moolenaar, 2011, Insights into autotaxin: How to produce and present a lipid mediator, Nat. Rev., 12, 674, 10.1038/nrm3188 · DOI · Paper page
  10. Blaho, 2011, Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors, Chem. Rev., 111, 6299, 10.1021/cr200273u · DOI · Paper page
  11. Okudaira, 2010, Biological roles of lysophosphatidic acid signaling through its production by autotaxin, Biochimie, 92, 698, 10.1016/j.biochi.2010.04.015 · DOI · Paper page
  12. Houben, 2011, Autotaxin and lpa receptor signaling in cancer, Cancer Metastasis Rev., 30, 557, 10.1007/s10555-011-9319-7 · DOI · Paper page
  13. Stracke, 1992, Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein, J. Biol. Chem., 267, 2524, 10.1016/S0021-9258(18)45911-X · DOI · Paper page
  14. Lee, 1996, Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells, Biochem. Biophys. Res. Commun., 218, 714, 10.1006/bbrc.1996.0127 · doi:10.1006/bbrc.1996.0127
  15. Perrakis, 2014, Autotaxin: Structure-function and signaling, J. Lipid Res., 55, 1010, 10.1194/jlr.R046391 · DOI · Paper page
  16. Zhang, 2012, Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive t cells, J. Immunol., 189, 3914, 10.4049/jimmunol.1201604 · DOI
  17. Teo, 2009, Lysophosphatidic acid (lpa) in vascular development and disease, IUBMB Life, 61, 791, 10.1002/iub.220 · doi:10.1002/iub.220
  18. Fukushima, 2002, Neurobiology of lysophosphatidic acid signaling, The Neurosci.: Rev. J. Bringing Neurobiol. Neurol. Psychiatry, 8, 540
  19. Spohr, 2008, Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation, J. Biol. Chem., 283, 7470, 10.1074/jbc.M707758200 · DOI
  20. Ye, 2002, Lysophosphatidic acid in neural signaling, Neuroreport, 13, 2169, 10.1097/00001756-200212030-00002 · DOI
  21. Yung, 2011, Lysophosphatidic acid signaling may initiate fetal hydrocephalus, Sci. Transl. Med., 3, 99ra87, 10.1126/scitranslmed.3002095 · DOI
  22. Yung, 2015, Lysophosphatidic acid signaling in the nervous system, Neuron, 85, 669, 10.1016/j.neuron.2015.01.009 · DOI · Paper page
  23. Knowlden, 2014, The autotaxin-lpa axis emerges as a novel regulator of lymphocyte homing and inflammation, J. Immunol., 192, 851, 10.4049/jimmunol.1302831 · DOI · Paper page
  24. Gennero, 2011, Absence of the lysophosphatidic acid receptor lpa1 results in abnormal bone development and decreased bone mass, Bone, 49, 395, 10.1016/j.bone.2011.04.018 · doi:10.1016/j.bone.2011.04.018
  25. Ye, 2010, Lysophosphatidic acid (Lpa) signaling in vertebrate reproduction, Trends Endocrinol. Metab.: TEM, 21, 17, 10.1016/j.tem.2009.08.003 · DOI
  26. Sims, 2013, Lysophosphatidic acid: A potential mediator of osteoblast-osteoclast signaling in bone, Biochim. Biophys. Acta, 1831, 109, 10.1016/j.bbalip.2012.08.001 · DOI
  27. Tsujiuchi, 2014, Lysophosphatidic acid receptors in cancer pathobiology, Histol. Histopathol., 29, 313
  28. Tsujiuchi, 2014, Diverse effects of lpa receptors on cell motile activities of cancer cells, J. Recept. Signal Transduct. Res., 34, 149, 10.3109/10799893.2013.876042 · DOI
  29. Yang, 2013, Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by lpa receptor 2, Oncol. Lett., 5, 1048, 10.3892/ol.2013.1107 · doi:10.3892/ol.2013.1107
  30. Sokolov, 2013, Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma, J. Surg. Res., 180, 104, 10.1016/j.jss.2012.10.054 · DOI
  31. Popnikolov, 2012, Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma, Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med., 33, 2237, 10.1007/s13277-012-0485-1 · DOI
  32. Komachi, 2012, Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo, Cancer Sci., 103, 1099, 10.1111/j.1349-7006.2012.02246.x · DOI
  33. Sako, 2006, Lysophosphatidic acid (Lpa)-induced vascular endothelial growth factor (Vegf) by mesothelial cells and quantification of host-derived vegf in malignant ascites, J. Surg. Res., 130, 94, 10.1016/j.jss.2005.08.007 · DOI
  34. Lin, 2008, Lysophosphatidic acid up-regulates vascular endothelial growth factor-c and lymphatic marker expressions in human endothelial cells, Cell. Mol. Life Sci., 65, 2740, 10.1007/s00018-008-8314-9 · DOI
  35. Samadi, 2011, Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance, Biochimie, 93, 61, 10.1016/j.biochi.2010.08.002 · DOI
  36. Sui, 2015, Lysophosphatidic acid inhibits apoptosis induced by cisplatin in cervical cancer cells, BioMed Res. Int., 2015, 598386, 10.1155/2015/598386 · doi:10.1155/2015/598386
  37. Venkatraman, 2015, Lysophosphatidate signaling stabilizes nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: Implications for cancer treatment, FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol., 29, 772, 10.1096/fj.14-262659 · DOI
  38. Sheng, 2015, Lysophosphatidic acid signalling in development, Development, 142, 1390, 10.1242/dev.121723 · DOI
  39. Fukushima, 2015, Comparative analyses of lysophosphatidic acid receptor-mediated signaling, Cell. Mol. Life Sci. CMLS, 72, 2377, 10.1007/s00018-015-1872-8 · DOI
  40. Xiang, 2013, Lysophospholipid receptor activation of rhoa and lipid signaling pathways, Biochim. Biophys. Acta, 1831, 213, 10.1016/j.bbalip.2012.09.004 · DOI
  41. Olivo, 2003, Rac activation by lysophosphatidic acid lpa1receptors through the guanine nucleotide exchange factor tiam1, J. Biol. Chem., 278, 400, 10.1074/jbc.M210151200 · DOI · Paper page
  42. Fang, 2000, Lysophosphatidic acid prevents apoptosis in fibroblasts via g(I)-protein-mediated activation of mitogen-activated protein kinase, Biochem. J., 352 Pt 1, 135, 10.1042/bj3520135 · doi:10.1042/bj3520135
  43. Ye, 2002, Lysophosphatidic acid as a novel cell survival/apoptotic factor, Biochim. Biophys. Acta, 1585, 108, 10.1016/S1388-1981(02)00330-X · DOI
  44. Bjorklof, 2008, The p110beta isoform of phosphoinositide 3-kinase signals downstream of g protein-coupled receptors and is functionally redundant with p110gamma, Proc. Natl. Acad. Sci. USA, 105, 8292, 10.1073/pnas.0707761105 · DOI · Paper page
  45. Hildebrandt, 1995, Lysophosphatidic acid induces inositol phosphate and calcium signals in exocrine cells from the avian nasal salt gland, J. Membarin Biol., 144, 49, 10.1007/BF00238416 · doi:10.1007/bf00238416
  46. Gennero, 1999, Effects of lysophosphatidic acid on proliferation and cytosolic ca++ of human adult vascular smooth muscle cells in culture, Thromb. Res., 94, 317, 10.1016/S0049-3848(99)00004-3 · DOI
  47. Litosch, 2009, Phosphatidic acid potentiates gαq stimulation of phospholipase c-β1 signaling, Biochem. Biophys. Res. Commun., 390, 603, 10.1016/j.bbrc.2009.10.013 · DOI
  48. Lee, 2007, Lpa4/gpr23 is a lysophosphatidic acid (Lpa) receptor utilizing gs-, gq/gi-mediated calcium signaling and g12/13-mediated rho activation, J. Biol. Chem., 282, 4310, 10.1074/jbc.M610826200 · DOI · Paper page
  49. Wittpoth, 1999, Regions on adenylyl cyclase that are necessary for inhibition of activity by βγ and g(Iα) subunits of heterotrimeric g proteins, Proc. Natl. Acad. Sci. USA, 96, 9551, 10.1073/pnas.96.17.9551 · DOI
  50. Takuwa, 2002, The edg family g protein-coupled receptors for lysophospholipids: Their signaling properties and biological activities, J. Biochem., 131, 767, 10.1093/oxfordjournals.jbchem.a003163 · DOI · Paper page
  51. Hecht, 1996, Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex, J. Cell Biol., 135, 1071, 10.1083/jcb.135.4.1071 · DOI · Paper page
  52. Lee, 1998, Sphingosine-1-phosphate as a ligand for the g protein-coupled receptor edg-1, Science, 279, 1552, 10.1126/science.279.5356.1552 · DOI · Paper page
  53. Contos, 2000, Genomic characterization of the lysophosphatidic acid receptor gene, lpa2/edg4, and identification of a frameshift mutation in a previously characterized cdna, Genomics, 64, 155, 10.1006/geno.2000.6122 · DOI
  54. Bandoh, 1999, Molecular cloning and characterization of a novel human g-protein-coupled receptor, edg7, for lysophosphatidic acid, J. Biol. Chem., 274, 27776, 10.1074/jbc.274.39.27776 · DOI · Paper page
  55. Archbold, 2014, Towards selective lysophospholipid gpcr modulators, Trends Pharmacol. Sci., 35, 219, 10.1016/j.tips.2014.03.004 · doi:10.1016/j.tips.2014.03.004
  56. Choi, 2008, Biological roles of lysophospholipid receptors revealed by genetic null mice: An update, Biochim. Biophys. Acta, 1781, 531, 10.1016/j.bbalip.2008.03.004 · DOI
  57. Anliker, 2013, Lysophosphatidic acid (lpa) and its receptor, lpa1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation, Glia, 61, 2009, 10.1002/glia.22572 · DOI
  58. Sakai, 2013, Lpa1-induced cytoskeleton reorganization drives fibrosis through ctgf-dependent fibroblast proliferation, FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol., 27, 1830, 10.1096/fj.12-219378 · DOI · Paper page
  59. Chrencik, 2015, Crystal structure of antagonist bound human lysophosphatidic acid receptor 1, Cell, 161, 1633, 10.1016/j.cell.2015.06.002 · DOI · Paper page
  60. Ohuchi, 2008, Expression patterns of the lysophospholipid receptor genes during mouse early development, Dev. Dyn., 237, 3280, 10.1002/dvdy.21736 · doi:10.1002/dvdy.21736
  61. Contos, 2002, Characterization of Lpa(2) (Edg4) and Lpa(1)/Lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to Lpa(2), Mol. Cell. Biol., 22, 6921, 10.1128/MCB.22.19.6921-6929.2002 · DOI · Paper page
  62. Xu, 2004, Trip6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor, J. Biol. Chem., 279, 10459, 10.1074/jbc.M311891200 · doi:10.1074/jbc.m311891200
  63. Lai, 2005, C-src-mediated phosphorylation of trip6 regulates its function in lysophosphatidic acid-induced cell migration, Mol. Cell. Biol., 25, 5859, 10.1128/MCB.25.14.5859-5868.2005 · doi:10.1128/mcb.25.14.5859-5868.2005
  64. Komachi, 2009, Lpa1 receptors mediate stimulation, whereas lpa2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites, Carcinogenesis, 30, 457, 10.1093/carcin/bgp011 · doi:10.1093/carcin/bgp011
  65. Hama, 2010, Lpa3, a unique g protein-coupled receptor for lysophosphatidic acid, Prog. Lipid Res., 49, 335, 10.1016/j.plipres.2010.03.001 · DOI
  66. Yanagida, 2011, Non-edg family lpa receptors: The cutting edge of lpa research, J. Biochem., 150, 223, 10.1093/jb/mvr087 · DOI
  67. Ishii, 2009, Non-edg family lysophosphatidic acid (lpa) receptors, Prostaglandins Lipid Mediat., 89, 57, 10.1016/j.prostaglandins.2009.06.001 · DOI
  68. Pamuklar, 2008, Individual heterogeneity in platelet response to lysophosphatidic acid: Evidence for a novel inhibitory pathway, Arterioscler. Thromb. Vasc. Biol., 28, 555, 10.1161/ATVBAHA.107.151837 · DOI
  69. Noguchi, 2003, Identification of p2y9/gpr23 as a novel g protein-coupled receptor for lysophosphatidic acid, structurally distant from the edg family, J. Biol. Chem., 278, 25600, 10.1074/jbc.M302648200 · DOI · Paper page
  70. Yanagida, 2013, Current progress in non-edg family lpa receptor research, Biochim. Biophys. Acta, 1831, 33, 10.1016/j.bbalip.2012.08.003 · DOI
  71. Sumida, 2010, Lpa4 regulates blood and lymphatic vessel formation during mouse embryogenesis, Blood, 116, 5060, 10.1182/blood-2010-03-272443 · DOI
  72. Yanagida, 2007, Lpa4/p2y9/gpr23 mediates rho-dependent morphological changes in a rat neuronal cell line, J. Biol. Chem., 282, 5814, 10.1074/jbc.M610767200 · doi:10.1074/jbc.m610767200
  73. Lee, 2008, Role of lpa(4)/p2y9/gpr23 in negative regulation of cell motility, Mol. Biol. Cell, 19, 5435, 10.1091/mbc.e08-03-0316 · DOI · Paper page
  74. Yanagida, 2009, Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/lpa6, J. Biol. Chem., 284, 17731, 10.1074/jbc.M808506200 · DOI · Paper page
  75. Pasternack, 2008, G protein-coupled receptor p2y5 and its ligand lpa are involved in maintenance of human hair growth, Nat. Genet., 40, 329, 10.1038/ng.84 · DOI · Paper page
  76. Araki, 2014, Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells, Growth Fact., 32, 117, 10.3109/08977194.2014.911294 · DOI
  77. Dong, 2014, Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3t3 cells, Biochem. Biophys. Res. Commun., 446, 585, 10.1016/j.bbrc.2014.03.016 · doi:10.1016/j.bbrc.2014.03.016
  78. Lee, 2015, Autotaxin and lpa1 and lpa5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis, Mol. Cancer Res. MCR, 13, 174, 10.1158/1541-7786.MCR-14-0263 · DOI
  79. Lee, 2009, P2y5 is a g(alpha)i, g(alpha)12/13 g protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion, Am. J. Physiol. Gastrointest. Liver Physiol., 297, G641, 10.1152/ajpgi.00191.2009 · doi:10.1152/ajpgi.00191.2009
  80. Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
  81. Schultze, 2011, Promiscuous affairs of pkb/akt isoforms in metabolism, Arch. Physiol. Biochem., 117, 70, 10.3109/13813455.2010.539236 · DOI · Paper page
  82. Yu, 2015, Akt isoforms in vascular disease, Vasc. Pharmacol., 71, 57, 10.1016/j.vph.2015.03.003 · DOI
  83. Dibble, 2009, A molecular link between akt regulation and chemotherapeutic response, Cancer Cell, 16, 178, 10.1016/j.ccr.2009.08.011 · DOI
  84. Newton, 2014, Turning off akt: Phlpp as a drug target, Annu. Rev. Pharmacol. Toxicol., 54, 537, 10.1146/annurev-pharmtox-011112-140338 · DOI · Paper page
  85. Sarbassov, 2005, Phosphorylation and regulation of akt/pkb by the rictor-mtor complex, Science, 307, 1098, 10.1126/science.1106148 · DOI · Paper page
  86. Jacinto, 2006, Sin1/mip1 maintains rictor-mtor complex integrity and regulates akt phosphorylation and substrate specificity, Cell, 127, 125, 10.1016/j.cell.2006.08.033 · DOI · Paper page
  87. Zeller, 2010, Pi3-kinase p110α mediates β1 integrin-induced akt activation and membrane protrusion during cell attachment and initial spreading, Cell Signal., 22, 1838, 10.1016/j.cellsig.2010.07.011 · DOI
  88. Riaz, A., Zeller, K.S., and Johansson, S. (2012). Receptor-specific mechanisms regulate phosphorylation of akt at ser473: Role of rictor in β1 integrin-mediated cell survival. PLoS ONE, 7. · DOI
  89. Fritsch, 2013, Ras and rho families of gtpases directly regulate distinct phosphoinositide 3-kinase isoforms, Cell, 153, 1050, 10.1016/j.cell.2013.04.031 · DOI · Paper page
  90. Santi, 2010, The akt isoforms are present at distinct subcellular locations, Am. J. Physiol., 298, C580, 10.1152/ajpcell.00375.2009 · DOI
  91. Villagrasa, 2012, Akt2 interacts with snail1 in the e-cadherin promoter, Oncogene, 31, 4022, 10.1038/onc.2011.562 · DOI
  92. Higuchi, 2008, Scaffolding function of pak in the pdk1-akt pathway, Nat. Cell Biol., 10, 1356, 10.1038/ncb1795 · DOI · Paper page
  93. Nakamura, 2008, Freud-1/aki1, a novel pdk1-interacting protein, functions as a scaffold to activate the pdk1/akt pathway in epidermal growth factor signaling, Mol. Cell. Biol., 28, 5996, 10.1128/MCB.00114-08 · DOI
  94. Luan, 2009, Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance, Nature, 457, 1146, 10.1038/nature07617 · DOI · Paper page
  95. Chan, 2014, Posttranslational regulation of akt in human cancer, Cell Biosci., 4, 1, 10.1186/2045-3701-4-59 · DOI · Paper page
  96. Lim, 2012, Cyld negatively regulates transforming growth factor-β-signalling via deubiquitinating akt, Nat. Commun., 3, 771, 10.1038/ncomms1776 · DOI · Paper page
  97. Kang, 2004, Serum bioactive lysophospholipids prevent trail-induced apoptosis via pi3k/akt-dependent cflip expression and bad phosphorylation, Cell Death Differ., 11, 1287, 10.1038/sj.cdd.4401489 · DOI
  98. Kim, 2008, Lysophosphatidic acid induces cell migration through the selective activation of akt1, Exp. Mol. Med., 40, 445, 10.3858/emm.2008.40.4.445 · DOI
  99. Li, 2003, Lysophosphatidic acid promotes survival and differentiation of rat schwann cells, J.Biol. Chem., 278, 9585, 10.1074/jbc.M213244200 · DOI
  100. Murga, 2000, A novel role for phosphatidylinositol 3-kinase beta in signaling from g protein-coupled receptors to akt, J. Biol. Chem., 275, 12069, 10.1074/jbc.275.16.12069 · DOI · Paper page
  101. Baudhuin, 2002, Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific, Mol. Pharmacol., 62, 660, 10.1124/mol.62.3.660 · DOI
  102. Kihara, 2015, Lysophospholipid receptors in drug discovery, Exp. Cell Res., 333, 171, 10.1016/j.yexcr.2014.11.020 · DOI · Paper page

Cited by

See all 66

Metadata

Authors
Riaz, A., Huang, Y., & Johansson, S.
Affiliations
  • Institute of Biochemistry and Biotechnology, University of the Punjab, 54590 Lahore, Pakistan
  • Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Center, 75123 Uppsala, Sweden
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-02-05
Volume
17
Issue
2
Pages
215
ISSN
1422-0067
Cited by
66
References
3
Language
en
Funders
  • The Swedish Cancer Foundation (130362)
  • The Higher Education Commission, Pakistan (02987/2008245)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.